Mitochondria Transfer-Based Therapies Reduce the Morbidity and Mortality of Leigh Syndrome

The authors demonstrated improved morbidity and mortality of the Ndufs4−/− mouse model of Leigh syndrome in multiple treatment paradigms associated with mitochondria transfer.